Mori Arkin got his start in business in 1972 helping his father run a small Israeli pharmaceutical distribution company. As big drug companies began creating their own distribution arms, the two moved into generics manufacturing, renaming the firm Agis Industries. They ran it under that name for two decades before selling it to pharma company Perrigo at a 21% premium to its roughly $700 million market capitalization. Arkin still has a stake in Perrigo, and he's still bullish on the healthcare sector. He's invested in Israeli hedge fund Sphera Global Healthcare and sits on its investment committee, and he's also poured more than $100M into 20 pharma and medical device companies, mostly based in Israel. He also owns shares in Israel's largest bank, Hapoalim, and French bank Societe Generale.